Loading...
Loading...
  • ABIOMED, Inc.: Leads amongst peers with strong fundamentals
    Capital Cubelast year

    ABIOMED, Inc.: Leads amongst peers with strong fundamentals

    ABIOMED, Inc. relative valuation is OVERVALUED and it has a fundamental analysis score of 94.Our analysis is based on comparing ABIOMED, Inc. with the following peers – Thoratec Corporation, Teleflex Incorporated, Cardica, Inc., HeartWare International, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, Spectranetics Corporation, Stereotaxis, Inc., AtriCure, Inc. and Kips Bay Medical, Inc. (THOR-US, (Read more...) The post ABIOMED, Inc.: Leads amongst peers with strong fundamentals appeared first on CapitalCube.

  • We're sorry this is all we were able to find about this topic.